Influence of galantamine in the inflammatory process and tissular lesions caused by Trypanosoma cruzi QM2 strain

Detalhes bibliográficos
Autor(a) principal: Camargo,Lucas Fadel
Data de Publicação: 2021
Outros Autores: Pinheiro,Guilherme Donzalisky, Oliveira,Priscilla Bianca de, Losada,Daniele Moraes, Chagas,Eduardo Federighi Baisi, Sperança,Márcia Aparecida, Chies,Agnaldo Bruno, Spadella,Maria Angélica, Martins,Luciamáre Perinetti Alves
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Revista da Sociedade Brasileira de Medicina Tropical
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822021000100339
Resumo: Abstract INTRODUCTION: Trypanosoma cruzi infection triggers an inflammatory process with exacerbated production of cytokines that stimulate inflammatory and anti-inflammatory signals, including the efferent anti-inflammatory signal known as the anti-inflammatory cholinergic pathway. Thus, the use of anticholinesterase drugs, such as galantamine, could minimize the inflammatory process caused by this disease. METHODS For the study at 30, 60, and 90 days, 120 Swiss mice were divided into three groups. Each group was subdivided into four subgroups: uninfected/untreated (CTRL), uninfected/treated (GAL), infected/untreated (INF), and infected/treated (GAL/INF). The infected groups were inoculated intraperitoneally with 0.1 ml of mouse blood containing 5 × 104 trypomastigote forms of the T. cruzi QM2 strain. The galantamine-treated groups received 5 mg/kg of galantamine orally, through pipetting. From each subgroup, the parameters of parasitemia, histopathological analysis, butyrylcholinesterase activity (BuChE), and functional study of the colon were evaluated. RESULTS: BuChE performance was observed when AChE was suppressed, with increased activity in the GAL/INF group similar to the INF group on the 30th day post infection, thus corroborating the absence of a significant difference in parasitic curves and histopathological analysis. CONCLUSIONS: The presence of an inflammatory process and nests of amastigotes, as well as evidence of reactivity to ACh and NOR, suggest that galantamine did not interfere with the colonic inflammatory response or even in colonic tissue parasitism at this stage of Chagas disease.
id SBMT-1_f6e94505af41c58fdb67d10dba4bee68
oai_identifier_str oai:scielo:S0037-86822021000100339
network_acronym_str SBMT-1
network_name_str Revista da Sociedade Brasileira de Medicina Tropical
repository_id_str
spelling Influence of galantamine in the inflammatory process and tissular lesions caused by Trypanosoma cruzi QM2 strainTrypanosoma cruziAcethylcholinesteraseButyrylcholinesteraseInflammatory processColonChagas diseaseAbstract INTRODUCTION: Trypanosoma cruzi infection triggers an inflammatory process with exacerbated production of cytokines that stimulate inflammatory and anti-inflammatory signals, including the efferent anti-inflammatory signal known as the anti-inflammatory cholinergic pathway. Thus, the use of anticholinesterase drugs, such as galantamine, could minimize the inflammatory process caused by this disease. METHODS For the study at 30, 60, and 90 days, 120 Swiss mice were divided into three groups. Each group was subdivided into four subgroups: uninfected/untreated (CTRL), uninfected/treated (GAL), infected/untreated (INF), and infected/treated (GAL/INF). The infected groups were inoculated intraperitoneally with 0.1 ml of mouse blood containing 5 × 104 trypomastigote forms of the T. cruzi QM2 strain. The galantamine-treated groups received 5 mg/kg of galantamine orally, through pipetting. From each subgroup, the parameters of parasitemia, histopathological analysis, butyrylcholinesterase activity (BuChE), and functional study of the colon were evaluated. RESULTS: BuChE performance was observed when AChE was suppressed, with increased activity in the GAL/INF group similar to the INF group on the 30th day post infection, thus corroborating the absence of a significant difference in parasitic curves and histopathological analysis. CONCLUSIONS: The presence of an inflammatory process and nests of amastigotes, as well as evidence of reactivity to ACh and NOR, suggest that galantamine did not interfere with the colonic inflammatory response or even in colonic tissue parasitism at this stage of Chagas disease.Sociedade Brasileira de Medicina Tropical - SBMT2021-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822021000100339Revista da Sociedade Brasileira de Medicina Tropical v.54 2021reponame:Revista da Sociedade Brasileira de Medicina Tropicalinstname:Sociedade Brasileira de Medicina Tropical (SBMT)instacron:SBMT10.1590/0037-8682-0201-2021info:eu-repo/semantics/openAccessCamargo,Lucas FadelPinheiro,Guilherme DonzaliskyOliveira,Priscilla Bianca deLosada,Daniele MoraesChagas,Eduardo Federighi BaisiSperança,Márcia AparecidaChies,Agnaldo BrunoSpadella,Maria AngélicaMartins,Luciamáre Perinetti Alveseng2021-11-23T00:00:00Zoai:scielo:S0037-86822021000100339Revistahttps://www.sbmt.org.br/portal/revista/ONGhttps://old.scielo.br/oai/scielo-oai.php||dalmo@rsbmt.uftm.edu.br|| rsbmt@rsbmt.uftm.edu.br1678-98490037-8682opendoar:2021-11-23T00:00Revista da Sociedade Brasileira de Medicina Tropical - Sociedade Brasileira de Medicina Tropical (SBMT)false
dc.title.none.fl_str_mv Influence of galantamine in the inflammatory process and tissular lesions caused by Trypanosoma cruzi QM2 strain
title Influence of galantamine in the inflammatory process and tissular lesions caused by Trypanosoma cruzi QM2 strain
spellingShingle Influence of galantamine in the inflammatory process and tissular lesions caused by Trypanosoma cruzi QM2 strain
Camargo,Lucas Fadel
Trypanosoma cruzi
Acethylcholinesterase
Butyrylcholinesterase
Inflammatory process
Colon
Chagas disease
title_short Influence of galantamine in the inflammatory process and tissular lesions caused by Trypanosoma cruzi QM2 strain
title_full Influence of galantamine in the inflammatory process and tissular lesions caused by Trypanosoma cruzi QM2 strain
title_fullStr Influence of galantamine in the inflammatory process and tissular lesions caused by Trypanosoma cruzi QM2 strain
title_full_unstemmed Influence of galantamine in the inflammatory process and tissular lesions caused by Trypanosoma cruzi QM2 strain
title_sort Influence of galantamine in the inflammatory process and tissular lesions caused by Trypanosoma cruzi QM2 strain
author Camargo,Lucas Fadel
author_facet Camargo,Lucas Fadel
Pinheiro,Guilherme Donzalisky
Oliveira,Priscilla Bianca de
Losada,Daniele Moraes
Chagas,Eduardo Federighi Baisi
Sperança,Márcia Aparecida
Chies,Agnaldo Bruno
Spadella,Maria Angélica
Martins,Luciamáre Perinetti Alves
author_role author
author2 Pinheiro,Guilherme Donzalisky
Oliveira,Priscilla Bianca de
Losada,Daniele Moraes
Chagas,Eduardo Federighi Baisi
Sperança,Márcia Aparecida
Chies,Agnaldo Bruno
Spadella,Maria Angélica
Martins,Luciamáre Perinetti Alves
author2_role author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Camargo,Lucas Fadel
Pinheiro,Guilherme Donzalisky
Oliveira,Priscilla Bianca de
Losada,Daniele Moraes
Chagas,Eduardo Federighi Baisi
Sperança,Márcia Aparecida
Chies,Agnaldo Bruno
Spadella,Maria Angélica
Martins,Luciamáre Perinetti Alves
dc.subject.por.fl_str_mv Trypanosoma cruzi
Acethylcholinesterase
Butyrylcholinesterase
Inflammatory process
Colon
Chagas disease
topic Trypanosoma cruzi
Acethylcholinesterase
Butyrylcholinesterase
Inflammatory process
Colon
Chagas disease
description Abstract INTRODUCTION: Trypanosoma cruzi infection triggers an inflammatory process with exacerbated production of cytokines that stimulate inflammatory and anti-inflammatory signals, including the efferent anti-inflammatory signal known as the anti-inflammatory cholinergic pathway. Thus, the use of anticholinesterase drugs, such as galantamine, could minimize the inflammatory process caused by this disease. METHODS For the study at 30, 60, and 90 days, 120 Swiss mice were divided into three groups. Each group was subdivided into four subgroups: uninfected/untreated (CTRL), uninfected/treated (GAL), infected/untreated (INF), and infected/treated (GAL/INF). The infected groups were inoculated intraperitoneally with 0.1 ml of mouse blood containing 5 × 104 trypomastigote forms of the T. cruzi QM2 strain. The galantamine-treated groups received 5 mg/kg of galantamine orally, through pipetting. From each subgroup, the parameters of parasitemia, histopathological analysis, butyrylcholinesterase activity (BuChE), and functional study of the colon were evaluated. RESULTS: BuChE performance was observed when AChE was suppressed, with increased activity in the GAL/INF group similar to the INF group on the 30th day post infection, thus corroborating the absence of a significant difference in parasitic curves and histopathological analysis. CONCLUSIONS: The presence of an inflammatory process and nests of amastigotes, as well as evidence of reactivity to ACh and NOR, suggest that galantamine did not interfere with the colonic inflammatory response or even in colonic tissue parasitism at this stage of Chagas disease.
publishDate 2021
dc.date.none.fl_str_mv 2021-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822021000100339
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822021000100339
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/0037-8682-0201-2021
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Medicina Tropical - SBMT
publisher.none.fl_str_mv Sociedade Brasileira de Medicina Tropical - SBMT
dc.source.none.fl_str_mv Revista da Sociedade Brasileira de Medicina Tropical v.54 2021
reponame:Revista da Sociedade Brasileira de Medicina Tropical
instname:Sociedade Brasileira de Medicina Tropical (SBMT)
instacron:SBMT
instname_str Sociedade Brasileira de Medicina Tropical (SBMT)
instacron_str SBMT
institution SBMT
reponame_str Revista da Sociedade Brasileira de Medicina Tropical
collection Revista da Sociedade Brasileira de Medicina Tropical
repository.name.fl_str_mv Revista da Sociedade Brasileira de Medicina Tropical - Sociedade Brasileira de Medicina Tropical (SBMT)
repository.mail.fl_str_mv ||dalmo@rsbmt.uftm.edu.br|| rsbmt@rsbmt.uftm.edu.br
_version_ 1752122162912690176